Zoledronic acid for the treatment of thalassemia-induced osteonecrosis

Haematologica. 2006 Sep;91(9):1155A.

Author

Pat Mahachoklertwattana¹

Affiliation

¹ Division of Endocrinology and Metabolism, Department of Pediatrics Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. rapmw@mahidol.ac.th

PMID: 16956807

No abstract available

Publication types

Comment

MeSH terms

Diphosphonates / administration & dosage*
Diphosphonates / pharmacology
Dose-Response Relationship, Drug
Humans
Imidazoles / administration & dosage*
Imidazoles / pharmacology
Osteonecrosis / drug therapy*
Osteonecrosis / etiology
Osteoporosis / drug therapy
Osteoporosis / etiology
Zoledronic Acid
beta-Thalassemia / complications*
beta-Thalassemia / drug therapy

Substances

Diphosphonates
Imidazoles
Zoledronic Acid